Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Dialysis Portfolio
Rockwell Medical a prominent healthcare company specializing in the development, manufacturing, commercialization, and distribution of hemodialysis products, has announced a significant new partnership with a leading manufacturer of medical equipment. This partnership aims to expand the Company’s product portfolio to include a single-use bicarbonate cartridge, which will be distributed to dialysis centers, hospital-based outpatient centers, and skilled nursing facilities across the United States. This move is expected to tap into a rapidly growing market opportunity, estimated at around $100 million, within the hemodialysis concentrates sector.

The new Dialysis Portfolio distribution agreement comes at a pivotal moment for the Dialysis Portfolio industry, as single-use bicarbonate disposables become an increasingly essential segment. This type of product is highly sought after in the industry, as dialysis providers look for efficient, safe, and compatible solutions for their dialysis machines. Rockwell Medical’s expertise in the dialysis field and its established distribution network will play a crucial role in the widespread availability of these products, further solidifying its position in the industry.
The Agreement
The distribution Dialysis Portfolio services agreement between Rockwell Medical and its Partner outlines the terms of the collaboration, which will see the Partner supply Rockwell with premium grade, single-use bicarbonate cartridges. The cartridges will be available in two sizes, 720 grams and 900 grams, both of which have received 510(k) approval from the U.S. Food and Drug Administration (FDA). This regulatory approval is an essential step, as it ensures that the bicarbonate cartridges meet the necessary standards for safety and effectiveness in the Dialysis Portfolio hemodialysis process.
Under the agreement, the Partner will retain responsibility for maintaining all regulatory approvals and meeting the necessary requirements to market and sell the bicarbonate cartridges in the United States. Rockwell Medical, leveraging its established distribution network and transportation subsidiary, will handle the delivery and distribution of these products to customers in dialysis centers and healthcare facilities nationwide.
Expanding the Product Portfolio
This new Dialysis Portfolio partnership marks a significant expansion of Rockwell Medical’s product portfolio. As the hemodialysis market evolves, there is a notable shift towards single-use bicarbonate cartridges, which offer significant advantages in terms of efficiency, safety, and ease of use. These cartridges are used to administer bicarbonate to dialysis patients, playing a critical role in balancing the blood’s pH during the dialysis process. The demand for single-use products in this segment is growing rapidly, driven by the increasing need for more convenient and effective solutions for dialysis providers.
Tim Chole, Chief Commercial Officer at Rockwell Medical, highlighted the Dialysis Portfolio company’s belief in the growing demand for single-use bicarbonate cartridges. “As the dialysis market continues to shift toward single-use bicarbonate cartridges, we believe there remains a growing unmet need for manufacturers and distributors to provide cartridges that are compatible with a range of dialysis machines,” Chole remarked. He emphasized that the market for such cartridges represents a significant opportunity for Rockwell Medical to diversify its offerings and expand its presence in the hemodialysis space.
The addition of theDialysis Portfolio bicarbonate cartridges is expected to complement Rockwell Medical’s existing portfolio of dialysis products, which already includes a range of hemodialysis concentrates and other vital products for dialysis providers. By diversifying its product line, Rockwell Medical is positioning itself to meet the changing needs of the dialysis industry while addressing the increasing demand for single-use solutions.
Meeting the Needs of the Dialysis Portfolio Industry
The dialysis industry is undergoing significant changes as providers seek more efficient, cost-effective, and patient-friendly solutions for the treatment of kidney disease. One of the driving factors behind the increasing demand for single-use bicarbonate cartridges is the need for products that are easier to handle, safer for patients, and more compatible with a variety of dialysis machines.
Single-use bicarbonate cartridges offer a range of benefits, including ease of use and a reduced risk of cross-contamination between patients. These advantages have made them an increasingly popular choice among dialysis providers. The move to single-use products also aligns with the broader healthcare industry trend toward simplifying medical processes, improving patient safety, and reducing costs.
Rockwell Medical’s partnership with a leading manufacturer of hemodialysis equipment enables the company to tap into this growing market while also leveraging its own distribution capabilities. Through its reliable distribution network and transportation subsidiary, Rockwell Medical is well-positioned to ensure that these products reach healthcare facilities quickly and efficiently, helping to address the needs of dialysis providers across the country.
Market Growth and Opportunity Dialysis Portfolio
The Dialysis Portfolio hemodialysis concentrates market is one of the fastest-growing segments within the broader healthcare industry. Single-use bicarbonate cartridges are a key part of this growth, as they are increasingly seen as the solution of choice for dialysis providers looking to improve their processes and outcomes. The market opportunity for these products is expected to grow significantly, driven by the rising number of patients requiring dialysis treatment, as well as the ongoing shift toward more efficient, user-friendly solutions.
With the single-use bicarbonate cartridge market estimated at $100 million, Rockwell Medical is poised to capitalize on this opportunity by adding these products to its existing portfolio. The company’s established relationships with dialysis centers, outpatient centers, and skilled nursing facilities will allow it to quickly integrate these products into its distribution network, driving adoption and meeting the growing demand for high-quality hemodialysis solutions.
The agreement with the Partner further enhances Rockwell Medical’s position in the hemodialysis market, enabling the company to offer a broader range of products and services to its customers. By continuing to innovate and expand its product offerings, Rockwell Medical is well-positioned to remain a key player in the dialysis industry, helping to shape the future of care for patients with kidney disease.
Launch and Future Outlook
Dialysis Portfolio Rockwell Medical plans to launch the single-use bicarbonate cartridge in late February 2025. This marks the beginning of a new chapter in the company’s efforts to support dialysis providers with high-quality, reliable products. With the launch of this new product, Rockwell Medical is demonstrating its commitment to meeting the evolving needs of the dialysis market and expanding its role as a trusted provider of hemodialysis solutions.
Rockwell Medical is focused on continuing to grow its product portfolio and strengthen its position in the dialysis market. The company is committed to supporting healthcare providers with innovative solutions that improve patient outcomes, enhance operational efficiency, and reduce costs. By continuing to expand its offerings and leverage its distribution network, Rockwell Medical is poised for success as it enters this rapidly growing segment of the hemodialysis market.
In conclusion, the partnership between Rockwell Medical and its Partner represents a strategic move that aligns with the company’s goals of expanding its product portfolio and addressing the growing demand for single-use bicarbonate cartridges in the hemodialysis market. With a reliable distribution network and a strong customer base, Rockwell Medical is well-positioned to capitalize on this opportunity and continue its mission of providing high-quality, life-saving solutions to dialysis providers and patients.